Back to Library
Skin

Melanotan I (Afamelanotide)

Selective melanocortin agonist for tanning and photoprotection with a milder side-effect profile than MT-II.

Emerging
Independent — no supplier kickbacksReviewed against 1 peer-reviewed source Last updated 2026
Typical Cycle
4 weeks
Dose Range
250–1000 mcg
Administration
subcutaneous
Evidence Level
Emerging
subcutaneous

What It Is

Melanotan I (afamelanotide) is a more selective melanocortin agonist than Melanotan II, favoring the MC1R receptor responsible for pigmentation. That selectivity gives it a milder side-effect profile — less nausea and far fewer of the libido/erection effects.

Crucially, it is an approved drug: marketed as Scenesse, it is approved in the US and EU to prevent phototoxicity in erythropoietic protoporphyria (EPP), a rare condition of extreme light sensitivity, where it is delivered as a clinical implant.

For tanning and photoprotection it is the gentler, better-characterized melanotan, though it still darkens moles and does not replace sunscreen.

What People Use It For

Tanning & Photoprotection

Stimulates pigmentation with a milder side-effect profile than MT-II.

Approved (Scenesse) for EPP; pigmentation effect well established

EPP / Light Sensitivity

Clinically approved to reduce phototoxic reactions in EPP.

Regulatory approval based on clinical trials

Skin Protection (adjunct)

Adds pigment-based protection, but is not a sunscreen replacement.

Supported, with the caveat that UV protection is partial

How Strong Is the Evidence?

We rate every peptide honestly across four dimensions — and tell you what it's not.

Emerging

Promising but early. Strong animal data and/or small/preliminary human studies, not yet confirmed in robust trials.

Who It's For

Men

Men wanting tanning/photoprotection with fewer side effects than MT-II

TanningPhotoprotection

Milder than Melanotan II but still darkens moles. Keep using sun protection. The more clinically grounded melanotan.

Women

Women seeking a gentler tanning/photoprotection option

TanningSkin protection

Fewer libido/nausea effects than MT-II. Monitor moles and continue sunscreen. Avoid in pregnancy.

♀ Women's Notes

Fewer libido/nausea effects than MT-II. Avoid in pregnancy.

Warnings & Safety

This section is always free and never locked.

Hard Stops — Do Not Use If:

Have moles assessed before use; monitor for changes.

Cautions — Use With Care If:

Milder than Melanotan II but still darkens moles/freckles.

Use sun protection — tanning does not eliminate UV risk.

What to expect — side effects

Standardized data for Melanotan I (Afamelanotide) is limited. These are the general effects to watch for with this type of compound.

Injection-site reactionCommon After injection

Rotate sites, use sterile technique, let alcohol dry before injecting.

Mild fatigue or headacheOccasional Early in a cycle

Hydrate and ease the dose; usually transient as your body adjusts.

Individual responses vary. Stop and consult a clinician for severe, persistent, or unexpected reactions.

Administration Guide

1
2
3
4

View Full Step-by-Step Guide

14 steps with photos, pro tips, and a dosing calculator.

Unlock Full Guide

7 days free. Then $24/month.

Dosing Reference

Conservative
███ mcg

████████ ████

Moderate
███ mcg

████████ ████

Aggressive
███ mcg

████████ ████

Frequency: ████ · Typical cycle: ██ weeks

Dosing info requires Core or Pro

Unlock Dosing

Research Sources

Always free. Never locked.

Community Outcomes DataPreview

A preview of the member outcomes dashboard. Real, anonymized Melanotan I (Afamelanotide) results populate here as the community logs data.

8.4/10
Avg Reported Benefit
sample
Skin
Most Common Goal
this peptide
4 wks
Typical Cycle
from the guide
Skin benefit reported82%
Noticed a clear effect61%
Would use again90%

Community Outcomes Data

See aggregated results from real users — benefit ratings, common goals, side effect frequency, and more.

Unlock with Core or Pro

Ready to start your Melanotan I (Afamelanotide) protocol?

Get the complete step-by-step guide, personalized dosing, and daily tracking.

View Full Guide

PepCompass provides educational information only. Nothing on this platform constitutes medical advice, diagnosis, or treatment. All content is for informational and research purposes only. Always consult a licensed healthcare provider before starting any peptide protocol. Individual results vary.